Login / Signup

Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial.

Lukas RobDavid CibulaPawel KnappPeter MallmannJaroslav KlatLubos MinarPavel BartosJosef ChovanecPetr ValhaMarek PlutaZdenek NovotnyJiri SpacekBohuslav MelicharDariusz KieszkoJitka FucikovaTereza HrnciarovaRoman Pawel KorolkiewiczMarek HraskaJirina BartunkovaRadek Spisek
Published in: Journal for immunotherapy of cancer (2022)
NCT02107937, EudraCT2010-021462-30.
Keyphrases